B. Riley Wealth Advisors’s abrdn Life Sciences Investors HQL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-11,500
| Closed | -$143K | – | 1487 |
|
|
2024
Q1 | $143K | Buy |
+11,500
| New | +$143K | ﹤0.01% | 1319 |
|
|
2023
Q4 | – | Sell |
-11,500
| Closed | -$143K | – | 1446 |
|
|
2023
Q3 | $143K | Sell |
11,500
-258
| -2% | -$3.22K | ﹤0.01% | 1319 |
|
|
2023
Q2 | $159K | Buy |
11,758
+5
| +0% | +$68 | ﹤0.01% | 1385 |
|
|
2023
Q1 | $164K | Buy |
11,753
+6
| +0.1% | +$84 | ﹤0.01% | 1327 |
|
|
2022
Q4 | $167K | Buy |
+11,747
| New | +$167K | ﹤0.01% | 1296 |
|
|
2022
Q2 | – | Sell |
-12,616
| Closed | -$209K | – | 1295 |
|
|
2022
Q1 | $209K | Sell |
12,616
-11,852
| -48% | -$196K | 0.01% | 1196 |
|
|
2021
Q4 | $471K | Sell |
24,468
-965
| -4% | -$18.6K | 0.01% | 840 |
|
|
2021
Q3 | $529K | Buy |
25,433
+41
| +0.2% | +$853 | 0.02% | 751 |
|
|
2021
Q2 | $545K | Buy |
25,392
+5,588
| +28% | +$120K | 0.02% | 728 |
|
|
2021
Q1 | $391K | Buy |
+19,804
| New | +$391K | 0.01% | 854 |
|
|
2017
Q1 | – | Sell |
-12,579
| Closed | -$214K | – | 543 |
|
|
2016
Q4 | $214K | Buy |
+12,579
| New | +$214K | 0.04% | 447 |
|